AI assistant
NextTrip, Inc. — Director's Dealing 2022
Jul 7, 2022
34837_dirs_2022-07-06_d51e76e4-559f-4b20-8f0e-5d8f2b420b77.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SIGMA LABS, INC. (SASI)
CIK: 0000788611
Period of Report: 2022-07-01
Reporting Person: Beckett Darren (CTO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-07-01 | Stock Option (right to buy) | $2.50 | A | 51927 | Acquired | 2027-07-01 | Common Stock (51927) | Direct |
| 2022-07-01 | Stock Appreciation Right | $1.30 | A | 97038 | Acquired | 2027-07-01 | Common Stock (97038) | Direct |
| 2022-07-01 | Stock Appreciation Right | $2.50 | A | 16944 | Acquired | 2027-07-01 | Common Stock (16944) | Direct |
Footnotes
F1: The stock option vests as follows: (i) 12,982 shares subject to the option vested on the date of grant, and (ii) the remaining 38,945 shares will vest in equal (as nearly as possible) monthly installments over the succeeding 36 months, subject, in each case, to the Reporting Person remaining an employee of the Issuer on the applicable vesting date.
F2: The stock appreciation right ("SAR") is payable in cash only, and vests on March 15, 2025, subject to the Reporting Person being in the continuous employ of the Issuer on the vesting date.
F3: The SAR is payable in cash only and vests as follows: (i) 25% of the SAR vested on the date of grant, and (ii) the balance of the SAR will vest in equal (as nearly as possible) monthly installments over the succeeding 36 months, subject, in each case, to the Reporting Person remaining an employee of the Issuer on the applicable vesting date.